Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.06 from other evidence | 0.00 |
| cell type Human Protein Atlas | group enriched outside the brain (t-cells) | 0.10 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | 6 Parkinson's trials, 0 stopped | 1.00 |
| literature PubMed | 95 Parkinson's papers of 61,329 | 0.40 |
| pathways Reactome | 4 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 4340
Sealed predictions
- IL2 in dopamine neurons, braak+0.58 (p 0.102) → +0.28 (p 0.459)receipt 4348
Swarm cases
receipt 4348: IL2 in dopamine neurons, braak
- power
- full sample +0.46 (p 0.052, n 18), 95% CI -0.00 to +0.77. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.48 (p 0.046, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.50 (p 0.036, n 18). not the mix.
- skeptic
- leave-one-out range +0.41 to +0.68, sign flips 0; without severely affected donors +0.46 (p 0.052, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for IL2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts